Covestor’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Covestor’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-62	Closed	–	–	2905
2024 Q1	$0	Sell	62 -3	-5%	-$4	﹤0.01%	2887
2023 Q4	$0	Buy	65 +47	+261%	+$41	﹤0.01%	2858
2023 Q3	$0	Sell	18 -3	-14%	-$6	﹤0.01%	2857
2023 Q2	$0	Sell	21 -1	-5%	-$4	﹤0.01%	2794
2023 Q1	$0	Sell	22 -10	-31%	-$46	﹤0.01%	2727
2022 Q4	$0	Buy	32 +19	+146%	+$119	﹤0.01%	2750
2022 Q3	$0	Sell	13 -2	-13%	-$30	﹤0.01%	2770
2022 Q2	$0	Sell	15 -4	-21%	-$55	﹤0.01%	2476
2022 Q1	$0	Buy	19 +1	+6%	+$16	﹤0.01%	2514
2021 Q4	$0	Buy	+18	New	+$345	﹤0.01%	2340

Covestor's NGM Position: Q2 2024 in Review

Covestor sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 62 shares.

Covestor first reported a position in NGM in Q4 2021 and held it in 10 quarters. The position peaked at $0 in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Covestor reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Covestor sold 62 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024.
Covestor first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
Covestor's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $0 in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Covestor's 13F filing for Q2 2024, filed 9 Aug 2024.